Pemetrexed and Gemcitabine in Patients With Advanced Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Gemcitabine
Related studies linked through entity extraction aliases.
Study of Paclitaxel, Carboplatin, and Gemcitabine Versus Gemcitabine and Vinorelbine for Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Weekly Docetaxel Versus Weekly Docetaxel/Gemcitabine in the Treatment of Non-Small Cell Lung Cancer in Elderly Patients
- Status
- COMPLETED
- Phase
- PHASE2
Neo-adjuvant Gemcitabine, Epirubicin, ABI-007 (GEA) in Locally Advanced or Inflammatory Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combination Gemcitabine, Carboplatin With or Without Trastuzumab in Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Weekly Gemcitabine and Trastuzumab in the Treatment of Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Weekly Gemcitabine, Epirubicin, and Docetaxel in Locally Advanced or Inflammatory Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Gemcitabine Plus Cisplatin Single Dose Versus Split Dose in the Treatment of Patients With Locally Advanced or Metastatic Breast Cancer After Failure of Anthracyclines and/or Taxanes
- Status
- COMPLETED
- Phase
- PHASE2
A Randomized Trial of Avastin + Gemcitabine + 5-Fluorouracil (5FU)/Folinic Acid Versus Avastin + Oxaliplatin + 5FU/Folinic Acid in Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Trial of Gemcitabine Combined With Vinorelbine as First Line Chemotherapy for Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Randomized Study Comparing Single Agent Gemcitabine Intravesical Therapy Versus Mitomycin C in Patients With Intermediate Risk Superficial Bladder Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Multicenter Phase 2 Trial Evaluating Cisplatin-Gemcitabine With Concomitant Thoracic Radiotherapy for Treatment of Inoperable Stage III Non Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
2nd Line Gemcitabine Monotherapy for Transitional Cell Carcinoma of Urothelium (TCC) After CDDP Regimen
- Status
- COMPLETED
- Phase
- PHASE2
Gemcitabine Combinations in Metastatic Breast Cancer (MBC), 1st Line
- Status
- COMPLETED
- Phase
- PHASE2
Gemcitabine in Combination With Cisplatin as Neoadjuvant NSCLC Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy for Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Neoadjuvant Sequential Administration of Two Gemcitabine Combinations in Operable Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Neo-Adjuvant Gemcitabine and Cisplatin in Treating Patients With Early Stage of Non Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Intravesical Gemcitabine Instillation Followed by Transurethral Resection for the Treatment of Patients With Superficial Bladder Cancer at Low Risk.
- Status
- COMPLETED
- Phase
- PHASE2
A Trial Of Gemcitabine Plus Paclitaxel And Gemcitabine Plus Docetaxel In Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2